Through analyzing node degree, it was shown that the top 10 cancer driver targets that interacted with uPAR modulators were EGFR, EPHA2, ERBB2, FLT3, RET, PDGFRA, KIT, ERBB4, MET and RPS6KA3 (Figure 2B). Here, FLT3 is linked to cancer.